Mitesco (MITI) Research & Development (2011 - 2026)

Mitesco's (MITI) quarterly Research & Development came in at $103533.0 in Q1 2026, up 1860.11% year-on-year from $5282.0 in Q1 2025, and up 74.02% on a QoQ basis from $59495.0 in Q4 2025.

Mitesco (MITI) Research & Development (2011 - 2026) Analysis & Trends

Mitesco (MITI) has 7 years of Research & Development data on file, last reported at $103533.0 in Q1 2026.

  • On a quarterly basis, Research & Development rose 1860.11% year-over-year to $103533.0 in Q1 2026; TTM through Mar 2026 was $185250.0, a 3407.19% increase from a year earlier, with the FY2025 full-year figure at $81717.0, changed N/A from the prior year.
  • Research & Development for Q1 2026 stood at $103533.0, up from $59495.0 in the prior quarter.
  • Over the last five years, Research & Development for MITI reached as high as $103533.0 in Q1 2026 and fell as low as $1100.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Veeva Systems 31.61 Bn 24.30 Bn 662.02 Mn 208.32 Mn
2 BrightSpring Health Services 14.73 Bn 13.83 Bn 482.22 Mn -
3 Healthequity 8.26 Bn 8.00 Bn 256.31 Mn 26.83 Mn
4 Hinge Health 5.90 Bn 5.58 Bn 154.23 Mn 30.34 Mn
5 10x Genomics 5.90 Bn 5.36 Bn 106.18 Mn 56.85 Mn
6 MiniMed 4.52 Bn 4.22 Bn 480.00 Mn 99.00 Mn
7 Waystar Holding 4.42 Bn 4.36 Bn 216.84 Mn 45.83 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn 39.11 Mn
9 Privia Health 3.17 Bn 2.75 Bn - 8.13 Mn
10 Mitesco 1.21 Mn 1.20 Mn - 103,533.00

Historic Data

Download Data
DateValue
Mar 31, 2026 103,533.00
Dec 31, 2025 59,495.00
Sep 30, 2025 1,100.00
Jun 30, 2025 21,122.00
Mar 31, 2025 5,282.00
Sep 30, 2015 172,289.00
Jun 30, 2015 172,289.00
Mar 31, 2015 194,699.00
Dec 31, 2014 225,875.00
Sep 30, 2014 222,934.00
Jun 30, 2014 222,934.00
Mar 31, 2014 365,037.00
Dec 31, 2013 244,946.00
Sep 30, 2013 191,378.00
Jun 30, 2013 483,426.00
Mar 31, 2013 329,613.00
Dec 31, 2012 167,032.00
Sep 30, 2012 114,976.00
Jun 30, 2012 273,985.00
Mar 31, 2012 338,164.00